![](/img/cover-not-exists.png)
Depletion of myeloid-derived suppressor cells during interleukin-12 immunogene therapy does not confer a survival advantage in experimental malignant glioma
Thaci, B, Ahmed, A U, Ulasov, I V, Wainwright, D A, Nigam, P, Auffinger, B, Tobias, A L, Han, Y, Zhang, L, Moon, K-S, Lesniak, M SVolume:
21
Language:
english
Journal:
Cancer Gene Therapy
DOI:
10.1038/cgt.2013.81
Date:
January, 2014
File:
PDF, 623 KB
english, 2014